226 related articles for article (PubMed ID: 29672156)
1. Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms.
Golden JM; Escobar OH; Nguyen MVL; Mallicote MU; Kavarian P; Frey MR; Gayer CP
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G259-G271. PubMed ID: 29672156
[TBL] [Abstract][Full Text] [Related]
2. The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis.
Lajczak-McGinley NK; Porru E; Fallon CM; Smyth J; Curley C; McCarron PA; Tambuwala MM; Roda A; Keely SJ
Physiol Rep; 2020 Jun; 8(12):e14456. PubMed ID: 32562381
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
[No Abstract] [Full Text] [Related]
4. Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition.
Lee J; Hong EM; Kim JH; Kim JH; Jung JH; Park SW; Koh DH; Jang HJ
Mol Biol Rep; 2021 Sep; 48(9):6231-6240. PubMed ID: 34392440
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids.
Stenman LK; Holma R; Eggert A; Korpela R
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G227-34. PubMed ID: 23203158
[TBL] [Abstract][Full Text] [Related]
6. The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing.
Mroz MS; Lajczak NK; Goggins BJ; Keely S; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G378-G387. PubMed ID: 29351391
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of EGFR by LPS induces COX-2 expression in enterocytes.
McElroy SJ; Hobbs S; Kallen M; Tejera N; Rosen MJ; Grishin A; Matta P; Schneider C; Upperman J; Ford H; Polk DB; Weitkamp JH
PLoS One; 2012; 7(5):e38373. PubMed ID: 22675459
[TBL] [Abstract][Full Text] [Related]
8. Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells.
Abdel-Latif MM; Inoue H; Reynolds JV
Eur J Cancer Prev; 2016 Sep; 25(5):368-79. PubMed ID: 26378497
[TBL] [Abstract][Full Text] [Related]
9. Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model.
Daruich A; Jaworski T; Henry H; Zola M; Youale J; Parenti L; Naud MC; Delaunay K; Bertrand M; Berdugo M; Kowalczuk L; Boatright J; Picard E; Behar-Cohen F
Neurotherapeutics; 2021 Apr; 18(2):1325-1338. PubMed ID: 33537951
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells.
Im E; Martinez JD
J Nutr; 2004 Feb; 134(2):483-6. PubMed ID: 14747693
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of colorectal cancer with ursodeoxycholic acid: pro.
Serfaty L
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S53-60. PubMed ID: 23141895
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485
[TBL] [Abstract][Full Text] [Related]
14. Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid.
Loddenkemper C; Keller S; Hanski ML; Cao M; Jahreis G; Stein H; Zeitz M; Hanski C
Int J Cancer; 2006 Jun; 118(11):2750-7. PubMed ID: 16385573
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein.
Khare S; Mustafi R; Cerda S; Yuan W; Jagadeeswaran S; Dougherty U; Tretiakova M; Samarel A; Cohen G; Wang J; Moore C; Wali R; Holgren C; Joseph L; Fichera A; Li YC; Bissonnette M
Nutr Cancer; 2008; 60(3):389-400. PubMed ID: 18444174
[TBL] [Abstract][Full Text] [Related]
16. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
Iwaki T; Ishizaki K; Kinoshita S; Tanaka H; Fukunari A; Tsurufuji M; Imada T
World J Gastroenterol; 2007 Oct; 13(37):5003-8. PubMed ID: 17854144
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion.
Fiorotto R; Spirlì C; Fabris L; Cadamuro M; Okolicsanyi L; Strazzabosco M
Gastroenterology; 2007 Nov; 133(5):1603-13. PubMed ID: 17983806
[TBL] [Abstract][Full Text] [Related]
19. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
Nowak G; Norén UG; Wernerson A; Marschall HU; Möller L; Ericzon BG
Transpl Int; 2005 May; 17(12):804-9. PubMed ID: 15815896
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral ursodeoxycholic acid on bile acids tolerance tests in healthy dogs.
Abraham LA; Charles JA; Holloway SA
Aust Vet J; 2004 Mar; 82(3):157-60. PubMed ID: 15088982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]